Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indigo naturalis for intractable ulcerative colitis
jRCTs031190156Active, not recruiting
- Start
- Jul 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial of indigo naturalis in autoimmune colitis. Primary endpoint: Clinical remission rate at week 8. Started Jul 2021; status: active, not recruiting.
02
Drugs
indigo naturalis
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCTs031190156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190156.